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Members of the B cell lymphoma 2 (Bcl-2) 
family regulate cell death in response to a wide 
range of stimuli, including growth factor or 
  cytokine deprivation, DNA damage caused by 
UV or γ irradiation, and certain anticancer 
drugs. Members of the Bcl-2 family are charac-
terized by structural motives called Bcl-2 homo-
logy (BH) domains. The prosurvival family 
members Bcl-2, Bcl-xL, Bcl-w, A1/Bfl  -1, and 
Mcl-1 contain up to four such homology 
  domains (BH1–4), whereas proapoptotic mem-
bers of the same family either possess three out 
of the four BH domains (e.g., Bax [Bcl-2–
  associated protein X], Bak [Bcl-2 antagonist/
killer], and Bok [Bcl-2–related ovarian killer]) 
or only the BH3 domain (1).
The BH3-only proteins Blk (Bik-like 
killer)/Bik (Bcl-2–like killer)/Nbk, Bid (Bcl-2–
  interacting domain death agonist), Bad (Bcl-2 
antagonist of cell death), Harakiri/death pro-
tein 5, Noxa/Apr, Bmf (Bcl-2 modifying 
  factor), Puma (p53–up-regulated modulator of 
apoptosis)/bbc3, and Bim (Bcl-2–  interacting 
mediator of cell death)/Bod (Bcl-2–related 
ovarian death gene) can all induce   apoptosis 
when overexpressed in cultured cells (1). This 
killing requires Bax or Bak (2), but how BH3-
only proteins are activated by physiological 
stimuli or in response to genotoxins remains 
only partly understood. According to a current 
model (3, 4), Bcl-2–like prosurvival molecules 
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investigated in mice lacking the individual genes identifying rate-limiting roles for Bim 
(Bcl-2–interacting mediator of cell death) and Puma (p53–up-regulated modulator of 
apoptosis) in apoptosis induction. The loss of Bim protects lymphocytes from apoptosis 
induced by cytokine deprivation and deregulated Ca++ fl  ux and interferes with the deletion 
of autoreactive lymphocytes and the shutdown of immune responses. In contrast, Puma is 
considered the key mediator of p53-induced apoptosis. To investigate the hypothesis that 
Bim and Puma have overlapping functions, we generated mice lacking both genes and 
found that bim−/−/puma−/− animals develop multiple postnatal defects that are not 
  observed in the single knockout mice. Most strikingly, hyperplasia of lymphatic organs 
is comparable with that observed in mice overexpressing Bcl-2 in all hemopoietic cells 
exceeding the hyperplasia observed in bim−/− mice. Bim and Puma also have clearly over-
lapping functions in p53-dependent and -independent apoptosis. Their combined loss 
promotes spontaneous tumorigenesis, causing the malignancies observed in Bcl-2 trans-
genic mice, but does not exacerbate the autoimmunity observed in the absence of Bim.
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can act as direct activators (Bid and Bim) or as derepressors 
(all others). In this model, the active form of Bid (caspase-
truncated (t)Bid) or Bim are thought to bind to Bcl-2 pro-
survival homologues in response to certain stress signals such 
as growth factor deprivation and prime mitochondria for the 
induction of apoptosis. Derepressor proteins are thought to 
free (t)Bid or Bim from sequestration by competitive binding 
to Bcl-2–like molecules. Once freed, the direct activators are 
proposed to interact physically with Bax and/or Bak, trigger-
ing their activation and subsequent apoptosis (3, 4). An al-
ternative model favors the idea that BH3-only proteins have 
diff  erent, only partially overlapping binding preferences for 
their prosurvival Bcl-2–like relatives, and individual BH3-
only proteins antagonize a specifi  c subset of Bcl-2–like pro-
survival molecules (5). According to this model, Bax and/or 
Bak are normally kept in check by binding to their prosur-
vival relatives and are activated when released as a result of 
BH3-only protein binding to the Bcl-2–like proteins (5).
The physiological role of BH3-only proteins has been 
  addressed by analyzing mice lacking individual members of 
the family. The absence of single BH3-only proteins is mostly 
compatible with embryogenesis, with the exception of the 
partial lethality of bim−/− embryos (6), suggesting a high de-
gree of redundancy among this class of proteins in early 
  embryonic development. In the adult organism, however, tissue 
and cell type–specifi  c defects have been observed in some but 
not all knockout mouse models (1). Lymphocytes from 
bim−/− mice were shown to be highly resistant to the eff  ects 
of cytokine deprivation or Ca2+ fl  ux and, to a lesser extend, 
also to glucocorticoid (GC) treatment (6). The loss of Bim 
causes lymphadenopathy and autoimmunity as a result of the 
ineffi   cient deletion of autoreactive thymocytes and immature 
B cells (7–9). In addition, Bim is also critical for the deletion 
of antigen-activated T cells during the shutdown of an im-
mune response (10, 11).
The BH3-only genes puma and noxa are direct transcrip-
tional targets of the tumor suppressor p53, and gene targeting 
in mice confi   rmed crucial cell type–dependent functions 
in p53-induced apoptosis for both proteins (12–14). Puma-
defi  cient mouse embryonic fi  broblasts and lymphocytes are 
highly refractory to treatment with γ irradiation or treatment 
with DNA-damaging drugs such as etoposide. Lymphocytes 
lacking puma also show decreased sensitivity to certain p53-
independent cell death stimuli such as cytokine deprivation, 
treatment with phorbol esters, or dexamethasone (14). 
Experiments with mice exposed to whole body γ irradiation 
or injected with GCs indicated that Puma and Bim might 
have overlapping functions in the killing of thymocytes and 
other lymphocyte populations in vivo (15).
We have generated mice lacking both Puma and Bim and 
demonstrate that these two proteins effi   ciently cooperate in 
mediating apoptosis in response to a broad range of p53-
  dependent and -independent apoptosis stimuli. Stress-induced 
cell death, spontaneous cell death, and death of activated 
T cells depend largely on these two BH3-only proteins. Auto-
immunity caused by Bim defi  ciency was not exacerbated by 
the additional loss of Puma despite pronounced lymphadeno-
pathy and thymic hyperplasia. Interestingly, the loss of Puma 
over Bim elevates the rate of spontaneous tumor develop-
ment observed in aged bim−/− mice, confi  rming the intrinsic 
tumor suppressor potential of these proteins.
RESULTS
Generation of bim−/−/puma−/− double-defi  cient mice
Mice lacking both Bim and Puma were generated by inter-
crossing double heterozygotes (bim+/−/puma+/−) and subse-
quently by intercrossing bim+/−/puma−/− males with double 
heterozygous females. Consistent with the previously reported 
partial embryonic lethality of bim−/− mice in intercrosses of 
bim+/− heterozygotes on the mixed 129SV×C57BL/6 back-
ground (6), only  44% of bim−/− and  40% of the expected 
numbers of bim−/−/puma−/− mice were born alive on the 
inbred C57BL/6 background. This indicates that a substan-
tial percentage of bim−/− and bim−/−/puma−/− embryos die 
in utero and suggests that Bim and Puma do not have over-
lapping functions during embryogenesis. Additional bim−/−/
puma−/− mice were generated by crossing bim−/−/puma−/− 
males with bim+/−/puma−/− females.
Histological examination of 8–12-wk-old bim−/−/puma−/− 
mice revealed the normal development of most organs, in-
cluding the lung, liver, heart, and kidneys (unpublished data). 
In contrast, spleens and lymph nodes were enlarged and 
  comparable in sizes with the ones observed in age-matched 
vav-bcl-2 transgenic (tg) mice but were clearly larger than 
those seen in bim−/− animals (P = 0.0001; Fig. S1, available at 
http://www.jem.org/cgi/content/full/jem.20061552/DC1). 
Although neither the loss of Bim or Puma nor Bcl-2 overex-
pression caused increased thymic size or cellularity (6, 14, 16), 
animals that lacked both Bim and Puma displayed a signifi  cant 
increase in thymic organ weight (P < 0.0021; Fig. S1).
Although increased in size, the thymus displayed an ar-
chitecture containing clearly demarcated cortical and medul-
lar regions but showed an increase in the number of medullar 
lymphocytes, as refl  ected in the reduced contrast between 
cortex and medulla in hematoxylin and eosin–stained sec-
tions (Fig. S2 a, available at http://www.jem.org/cgi/
content/full/jem.20061552/DC1). The architectures of spleens 
(Fig. S2 b) and lymph nodes (not depicted) were strongly al-
tered in bim−/− as well as in bim−/−/puma−/− mice and were 
characterized by severely enlarged T and B cell zones. Areas 
of red pulp were most pronounced in the spleens of bim−/−/
puma−/− animals (Fig. S2 b; and see Fig. 2 e).
Impaired T lymphocyte development and thymic hyperplasia 
caused by the combined absence of Bim and Puma
The loss of Puma does not cause any obvious defects in lym-
phocyte development, whereas the absence of Bim strongly 
impairs T and B cell development, in part because of the fail-
ure of negative selection processes (1). Thymic cellularity is 
not increased in Bim-defi  cient or Bcl-2 tg mice, but animals 
of both genotypes display a substantial increase in mature 
CD4+8− as well as CD4−8+ single-positive T cells and an JEM VOL. 203, December 25, 2006  2941
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abnormal decrease in immature double-positive (DP) CD4+8+ 
thymocytes (Fig. 1 a). Cell counting revealed a close to 
  twofold increase in the total thymocyte number in bim−/−/
puma−/− mice compared with all other genotypes (P ≤ 0.037; 
Fig. 1 b). Compared with bim−/− mice, bim−/−/puma−/− 
mice had an even greater reduction in the percentage of 
CD4+8+ DP thymocytes (P = 0.0002; Fig. 1 a), but their 
  total number was larger than that seen in bim−/− mice, ap-
proaching that found in WT animals (Fig. 1 b). In compari  son 
to bim−/− and vav-bcl-2 tg mice, bim−/−/puma−/− mice had 
twice as many CD4−8− double-negative (DN) and CD4+8− 
as well as CD4−8+ thymocytes, amounting to a four- to seven-
fold increase compared with WT mice (Fig. 1 b). A more 
detailed FACS analysis of CD4−8− thymocytes revealed that 
>90% of these DN cells were CD25−CD44− pro–T4 cells. 
A similar percentage of these cells was also   observed in bim−/− 
and  vav-bcl-2 tg mice (Fig. 1 c). The majority of these 
CD4−8−CD25−CD44− (pro-T4) cells expressed a TCR-β 
on their surface (Fig. 1, d and e), indicating that they had 
  undergone β selection and may represent mature DN T cells 
(17). Collectively, our data demonstrate that the additional 
loss of Puma exacerbates the defects in T cell development in 
the thymus caused by the loss of Bim.
Interestingly, thymic hyperplasia was never observed 
in puma−/−, bim−/−, or vav-bcl-2 tg mice (Fig. S1 and Fig. 
1 b). Its occurrence in bim−/−/puma−/− mice indicated that 
Puma, together with Bim, may antagonize a Bcl-2 pro-
survival homologue that is not effi   ciently blocked by Bim 
alone and cannot be replaced by Bcl-2 overexpression. We 
  hypothesized that the loss of puma may synergize with Bcl-2 
Figure 1.  Combined loss of Puma and Bim causes the accumulation 
of immature thymocytes. (a) Representative dot blots of stained thy-
mocytes from animals of each genotype showing the percentages 
of CD4−8−, CD4+8+, CD4+8−, and CD4−8+ cells. (b) Thymic cellularity 
was assessed using a hemocytometer and trypan blue exclusion. The 
percentages of the various thymocyte subsets and total thymic cellu-
larity were used to calculate the absolute numbers of CD4−8−, 
CD4+8+, CD4+8−, and CD4−8+ thymocytes. (c and d) Single-cell 
  suspensions were stained with a combination of fluorochrome-
  conjugated anti  bodies recognizing CD4, CD8, CD25, and CD44 (c) 
or CD4, CD8, and TCR-β (d) to determine the percentage and overall 
numbers of pro–T cells (CD4−8−) and the pro–T1 (CD25−44+), pro–T2 
(CD25+44+), pro–T3 (CD25+44−), and pro–T4 subsets (CD25−44−). 
(e) Representative histograms of TCR-β expression on CD4−8− DN 
thymocytes. Bars represent means ± SEM (error bars) of 5–10 animals 
of each genotype.2942  BIM−/−PUMA−/− MICE SHOW MULTIPLE APOPTOSIS DEFECTS | Erlacher et al.
overexpression to cause thymic hyperplasia and generated 
puma−/− mice expressing the vav-bcl-2 transgene. Comparing 
the thymi derived from 8–10-wk-old mice lacking puma 
with those lacking puma and overexpressing Bcl-2 did 
not reveal an abnormal increase in organ weight, overall 
cellularity, or subset composition (Fig. S3 a, available at 
http://www.jem.org/cgi/content/full/jem.20061552/DC1; 
and not depicted). Thus, Bcl-2 overexpression may be un-
able to fully neutralize Bim and Puma, but an increase in 
another prosurvival family member might be able to do so, 
thereby facilitating thymic hyperplasia. Bcl-xL can avidly 
bind to Bim and Puma (18) and delays spontaneous, anti-
cancer drug–, or GC-induced death when overexpressed 
in thymocytes (19). In contrast to our expectations, double-
tg off  spring from intercrosses of lck-bcl-xL and vav-bcl-2 tg 
mice had smaller thymic organ weights and cellularity than 
in WT, puma−/−, and puma−/−/vav-bcl-2 tg mice (Fig. S3, a 
and b). This indicates that simply increasing the pool of pro-
survival Bcl-2 homologues is not suffi   cient to cause thymic 
hyperplasia and may even inhibit the thymocyte prolifera-
tion of immature T cell progenitors. Remarkably, lethally 
irradiated Ly5.1 recipient mice reconstituted with bone mar-
row cells lacking both Bim and Puma had thymus sizes and 
cellularities indistinguishable from that of WT mice or mice 
reconstituted with WT bone marrow (Fig. S3 c). However, 
thymic subset composition refl  ected those of unmanipulated 
bim−/−/puma−/− mice (unpublished data). Therefore, we 
conclude that a thymocyte-independent contribution (per-
haps mediated by increased thymic epithelial cell survival) 
in combination with the decreased apoptosis of developing 
thymocytes may be responsible for causing thymic hyperpla-
sia in bim−/−/puma−/−mice.
Combined loss of Puma and Bim perturbs cellular 
homeostasis in the bone marrow
Analysis of bone marrow samples from the femora of WT, 
bim−/−, puma−/−, and bim−/−/puma−/− mice revealed that 
they all had equal cell numbers of hemopoietic cells. In con-
trast, increased cellularity was observed in vav-bcl-2 tg mice 
(Table S1, available at http://www.jem.org/cgi/content/
full/jem.20061552/DC1). When analyzing the composition 
of B cell subsets, we observed that the percentage and total 
number of B220+CD43+sIgM− pro–B cells was elevated in 
animals lacking Bim or those overexpressing Bcl-2. The ad-
ditional loss of Puma did not cause a further increase in pro–B 
cell numbers in bim−/− mice (Table S1). The percentage and 
number of B220+CD43−sIgM− pre–B cells did not sig-
nifi  cantly diff  er between genotypes (P ≥ 0.08; Table S1). 
Consistent with a previous study (6), we found that the num-
bers of sIgMlowsIgDhigh mature recirculating B cells were ele-
vated about twofold in bim−/− mice and that the loss of Puma 
did not cause a further accumulation of these cells (Table S1). 
In contrast, Bcl-2 tg mice contained even higher cell num-
bers of mature recirculating B cells than bim−/− or bim−/−/
puma−/− mice (Table S1), suggesting that additional BH3-only 
proteins besides Bim and Puma regulate B cell homeostasis. 
The numbers of recirculating CD4+ or CD8+ mature T cells 
was also elevated in the absence of Bim, but, in contrast to B 
cells, the additional loss of Puma drastically increased the 
number of these cells (Table S1). The numbers of nucleated 
Ter119+ erythroid cells and granulocytes were abnormally 
reduced in the bone marrow of bim−/−, bim−/−/puma−/−, 
and vav-bcl-2 tg mice (Table S1).
Combined absence of Bim and Puma causes severe 
splenomegaly and lymphadenopathy
Overexpression of Bcl-2 throughout the hemopoietic com-
partment in vav-bcl-2 tg mice causes severe splenomegaly and 
lymphadenopathy to an extent that exceeds the one elicited 
by the loss of Bim (16, 20). This indicates that the over-
expression of Bcl-2 antagonizes not only Bim but also addi-
tional BH3-only proteins that are relevant for lymphocyte 
homeostasis. In accordance with this hypothesis, we observed 
that bim−/−/puma−/− mice had a clearly more extensive spleno-
megaly and lymphadenopathy than bim−/− mice; in fact, it 
was comparable with that observed in vav-bcl-2 tg mice. The 
combined loss of Bim and Puma caused a fourfold increase in 
spleen cell numbers when compared with WT spleens (P < 
0.0001) and a twofold increase when compared with Bim-
defi  cient spleens (P = 0.007). Spleens from vav-bcl-2 tg ani-
mals were comparable in size and cellularity with spleens 
from bim−/−/puma−/− animals (Fig. 2 a). 
The percentage of immature sIgMhighsIgDlow and mature 
sIgMlowsIgDhigh B cells and CD4+ as well as CD8+ T cells 
were similar to the ones observed in spleens from bim−/− or 
vav-bcl-2 tg animals, but the combined loss of Puma and Bim 
was required to raise lymphocyte numbers to the levels ob-
served in mice overexpressing Bcl-2 (not depicted and Fig. 2, 
a and b). Interestingly, bim−/−- and bim−/−/puma−/−-like 
vav-bcl-2 tg mice displayed an increase in the percentage of 
activated CD44hiCD62Llow T lymphocytes in spleens (Fig. 2 c) 
and lymph nodes (Table S2, available at http://www.jem.
org/cgi/content/full/jem.20061552/DC1), indicating that 
Bim and Puma might have an overlapping role in the pro-
grammed death of activated T cells. In line with a possible 
role for Puma in this process, we noted that the percentage 
and number of T cells that had a CD44hiCD62Llow pheno-
type appeared mildly but repeatedly elevated in puma−/− 
mice (Fig. 2 c).
White blood cell numbers in bim−/− or bim−/−/puma−/− 
mice did not reach the levels observed in vav-bcl-2 tg mice 
(Table S3, available at http://www.jem.org/cgi/content/
full/jem.20061552/DC1). As in the lymph nodes and spleens, 
mature T cells were signifi  cantly higher in double- defi  cient 
animals than in bim−/− mice (P ≤ 0.033), matching the num-
bers observed in vav-bcl-2 tg mice. Interestingly, the number 
of mature B cells was comparable between bim−/− or bim−/−/
puma−/− mice but was signifi  cantly smaller than those found 
in vav-bcl-2 tg mice (P ≤ 0.04), explaining the diff  erence in 
total white blood cell number (Table S3). This observation 
further supports our notion that B cell homeostasis is not 
regulated by Puma and that Bim may act in concert with at JEM VOL. 203, December 25, 2006  2943
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least one additional proapoptotic factor that can be inhibited 
by Bcl-2.
Mice overexpressing Bcl-2 have reduced numbers of 
committed myeloid progenitors in their bone marrow but an 
increase of these cells in the spleen, most likely as a result of 
extramedullary hemopoiesis (16). Similarly, mice lacking 
Bim accumulate myeloid cells in secondary lymphatic organs 
such as the spleen (20), and the loss of Puma was shown to 
protect bone marrow–derived myeloid precursor cells from 
the eff  ects of aberrant c-myc oncogene expression and growth 
factor deprivation (13). Our analysis revealed that the num-
ber of Mac-1+Gr-1− macrophages was signifi  cantly increased 
in the spleens of bim−/−/puma−/− and vav-bcl-2 tg mice (P < 
0.004) but only marginally in puma−/− or bim−/− animals 
(Fig. 2 d). In the peripheral blood, only vav-bcl-2 tg mice dis-
played a signifi  cant increase (P = 0.001) of Mac-1+Gr-1− 
monocytes (Table S3). These fi  ndings are consistent with our 
observations in bone marrow, where only Mac-1+Gr-1− 
monocytes/macrophages but not granulocytes were found to 
be elevated when Bcl-2 was overexpressed (Table S1). In 
contrast, granulocytes in spleens and peripheral blood were 
comparable in all genotypes (Fig. 2 d and Table S3). Even 
though they are decreased in number in the bone marrow of 
bim−/−, bim−/−/puma−/−, and vav-bcl-2 tg mice (Table S1), 
possibly as a result of the displacement by increased numbers 
of recirculating mature lymphocytes, these numbers are able 
to replenish the daily granulocyte loss in the periphery.
Consistent with the abnormal expansion of red pulp seen 
in the histological section of the spleens from bim−/−/puma−/− 
and vav-bcl-2 tg mice (Fig. S2 and not depicted), nucleated 
Ter119+ erythroid cells were elevated when compared with 
the other genotypes. The absence of bim alone caused only a 
minor increase in the number of Ter119+ cells, but this in-
crease was much more pronounced when Bim and Puma 
were lacking or when Bcl-2 was overexpressed (Fig. 2 e). 
This suggests that lymphadenopathy-mediated displacement 
of erythroid progenitors from the bone marrow, like that ob-
served in bim−/−, bim−/−/puma−/−, or vav-bcl-2 tg mice (Table 
S1), can be compensated for by extramedullary erythropoiesis 
in the spleen (Fig. 2 e and not depicted).
Bim and Puma cooperate in apoptosis induction 
in lymphocytes
The abnormal accumulation of activated T cells in the spleen 
and lymph nodes of bim−/−/puma−/− mice prompted us to 
investigate the role of these proteins in the death of activated 
T cells. As previously reported (6), bim−/− T cell blasts sur-
vived IL-2 deprivation in culture substantially better than T 
cell blasts from WT mice (Fig. 3 a). The loss of Puma pro-
vided only transient protection from IL-2 deprivation–
  induced death, which was most pronounced after 24 h, but T 
cell blasts died rapidly thereafter (Fig. 3 a). However, the 
combined loss of Puma and Bim protected T cell blasts from 
IL-2 deprivation–induced death more potently than the loss 
of Bim and almost as potently as Bcl-2 overexpression. This 
indicates that Puma, together with Bim, plays an essential 
role in activated T cell death (Fig. 3 a).
To assess the relevance of this observation for the deletion 
of activated T cells in vivo, we generated a cohort of animals 
containing a Bim/Puma double-defi  cient hemopoietic  system 
(plus all relevant controls) by reconstituting lethally irradiated 
C57BL/6-Ly5.1 recipients with bone marrow–derived stem 
cells of the desired genotype. 8 wk after successful   reconstitution, 
these animals were challenged with the bacterial superantigen 
Figure 2.  Splenomegaly caused by the loss of Bim is enhanced by 
concomitant Puma defi  ciency. Spleens from animals of the indicated 
genotypes were harvested. (a) Total cellularity determined by counting an 
aliquot of the single-cell suspensions using a hemocytometer and trypan 
blue exclusion. (b) Total cellularity of splenic T and B cells was determined 
by staining cell suspensions with fl  uorescence-conjugated antibodies 
specifi  c for CD4 and CD8 or IgM and IgD, respectively. (c) The absolute 
numbers of activated CD44highCD62Llow T cells were determined by stain-
ing splenic T cells with antibodies specifi  c for CD4 or CD8 in combination 
with antibodies to CD44 and CD62L. (d and e) Absolute numbers of gran-
ulocytes (Mac-1+Gr-1+), macrophages (Mac-1+Gr-1−; d), and nucleated 
erythroid cells (Ter119+; e), were determined by fl  ow cytometric analysis 
using fl  uorescence-conjugated antibodies. Bars represent means ± SEM 
(error bars) of 5–10 animals of each genotype.2944  BIM−/−PUMA−/− MICE SHOW MULTIPLE APOPTOSIS DEFECTS | Erlacher et al.
Staphylococcus enterotoxin B (SEB) that specifi  cally activates 
T cells expressing a Vβ8-containing TCR. The expansion of 
Vβ8-bearing T cells in peripheral blood was monitored 0, 3, 
8, and 15 d after SEB challenge. Consistent with previously 
published data (10), we observed that the expansion of Vβ8+ 
T cells lacking Bim (or Bim and Puma) was initially delayed 
compared with WT or puma−/− T cells (Fig. 3 c). This may 
be caused by a defect in entering the cell cycle, a phenome-
non that has been well documented in lymphocytes over-
expressing Bcl-2 (21). The percentages of Bim as well as 
Bim/Puma double-defi  cient Vβ8+ T cells were still elevated 
at day 15, whereas Puma-defi  cient cells regressed as rapidly as 
WT cells (Fig. 3 b). This was surprising given our in vitro 
data and suggests that a benefi  cial eff  ect of Puma defi  ciency 
may only become apparent at later time points. As expected, 
the percentage of Vβ6+ T cells, which do not respond to 
SEB, did not change during the entire time course of the 
  experiment (Fig. 3 b). When analyzing the fate of Vβ8+ T cells 
in lymph nodes and spleen 3 or 6 wk after SEB challenge, we 
again observed increased percentages in bim−/− and bim−/−
puma−/− double-defi  cient animals (Fig. 3 c). However, we 
also noted that the combined loss of Puma and Bim did not 
protect Vβ8+ T cells more effi   ciently than the loss of Bim 
alone (Fig. 3 d). Because of the limited number of animals 
available to us, we were unable to determine whether a diff  e-
rence in the deletion effi   ciency may have become apparent 
beyond 6 wk.
Bim and Puma cooperate in stress-induced apoptosis
The extensive lymphoid hyperplasia strongly suggests that 
lymphocytes lacking both Bim and Puma may exhibit se-
vere apoptosis defects. To assess quantitative diff  erences in 
stress-induced apoptosis, we isolated immature DP thymo-
cytes and mature splenic T and B cells of 8–12-wk-old WT, 
bim−/−, puma−/−, bim−/−/puma−/−, and vav-bcl-2 tg mice, 
put them into culture, and subjected them to cytokine with-
drawal, treatment with the GC dexamethasone, the phorbol 
ester PMA, the calcium ionophore ionomycin, the broad-
spectrum kinase inhibitor staurosporine, γ irradiation, the 
DNA-damaging drug etoposide, or the glycosylation inhi-
bitor and ER stressor tunicamycin. Cell viability was moni-
tored over a period of 96 h by means of annexin V/propidium 
iodide (PI) staining and fl  ow cytometric analysis. Thymocytes 
lacking both Bim and Puma survived cytokine deprivation, 
γ irradiation, and treatment with staurosporine,   tunicamycin, 
or etoposide signifi   cantly better than cells lacking only 
Bim or Puma and, of course, WT cells (P ≤ 0.04; Fig. 4 a 
and not depicted). In contrast, other death stimuli such as 
phorbol ester or ionomycin killed primarily in a Puma- or 
Bim-dependent manner, respectively (Fig. S4 a, available at 
http://www.jem.org/cgi/content/full/jem.20061552/DC1). 
Death by ligation of Fas was independent of Bim and Puma 
(Fig. S4 a).
In response to most cell death inducers tested, mature T 
and B cells lacking Bim and Puma behaved in a manner simi-
lar to thymocytes (Fig. 4, b and c; and not depicted). Interest-
ingly, mature T and B cells from bim−/−/puma−/− mice were 
almost as resistant to cytokine deprivation or treatment with 
GC as cells overexpressing Bcl-2 (Fig. 4, b and c), indicating 
that Bim and Puma mediate most of this killing. To assess 
whether GC-induced cell death would entirely depend on 
Bim and Puma, double-defi  cient animals were injected i.p. 
Figure 3.  The death of activated T cells is mediated by Bim and 
Puma. (a) Enriched T cells were stimulated for 72 h with 2 μg/ml ConA 
and 100 U/ml IL-2. Cell viability was assessed at the indicated time points 
after cytokine deprivation by PI exclusion and fl  ow cytometric analysis. 
Means of four or more independent experiments ± SEM (error bars) are 
given, representing cells generated from fi  ve to six mice per genotype. 
(b) Ly5.1+ mice reconstituted for 8 wk with bone marrow cells derived from 
the indicated genotypes (all verifi  ed to contain >95% donor-derived 
Ly5.2+ leukocytes in peripheral blood) were challenged with SEB. The 
percentages of Vβ8+ and Vβ6+ T cells in peripheral blood were deter-
mined after 0, 3, 8, and 15 d. Two independent experiments using three to 
four animals per genotype gave similar results, so the data were pooled. 
(c) 3 or 6 wk after SEB challenge, animals were killed, single-cell suspen-
sions from spleen and inguinal lymph nodes were counted, and aliquots 
were stained using antibodies specifi  c for CD4 and Vβ8+ followed by fl  ow 
cytometric analysis. Two independent experiments using two different 
donor animals per genotype gave similar results, so the data were pooled. 
(b and c) Mean percentages ± SD (error bars) are given.JEM VOL. 203, December 25, 2006  2945
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with 500 μg dexamethasone. We observed that the loss of 
either Puma or Bim expression provided limited, albeit 
signifi  cant (P < 0.042), protection (Fig. 5 a). However, in 
the absence of Bim and Puma, the overall thymic cellular-
ity was reduced only by  20% (Fig. 5 a). The numbers of 
DP thymocytes that was recovered in bim−/− or puma−/− 
single knockout animals 20 h after GC injection was sub-
stantially smaller than the number of DP thymocytes from 
double-  defi  cient animals (Fig. 5 a). Similarly, more ma-
ture T and B cells were recovered from the spleens of 
double-deficient   animals than from mice lacking Bim or 
Puma (Fig. 5 b). This indicates that Bim and Puma have 
overlapping roles in the GC-induced killing of thymo-
cytes and mature T cells, but the combined loss of these 
BH3-only proteins does not confer absolute GC resistance 
in vivo.
Hyper–𝗄-globulinemia and autoantibody production 
in bim−/− and bim−/−puma−/− mice
Autoimmune glomerulonephritis observed in bim−/− mice 
on the mixed (129SV×C57BL/6) genetic background is 
caused by defects in the negative selection of autoreactive 
B (9) and T cells (7, 8) and excessive production of Ig 
from abnormally persisting plasma cells in these animals (6). 
However, fatal autoimmune pathology was not seen in 
bim−/− mice backcrossed onto the C57BL/6 genetic back-
ground (20), which is consistent with the polygenetic   nature 
of this disease. To assess whether the combined loss of Bim 
and Puma may lead to autoimmune pathology on the 
C57BL/6 background, we monitored B cell eff  ector func-
tion. Serum Ig levels were quantifi  ed in 8–12-wk-old ani-
mals of all genotypes. Consistent with previous observations 
on the mixed (C57BL/6×129SV) genetic background, the 
Figure 4.  Bim and Puma can act synergistically in cell death activation. 
(a–c) FACS-sorted CD4+8+ thymocytes (a), Thy1+ splenic T cells (b), or 
B220+ splenic B cells (c) derived from animals of the indicated genotypes 
were cultured in regular medium (spontaneous death), exposed to 
γ irradiation (10 Gy), or cultured in the presence of 1 μg/ml etoposide, 
10 μg/ml tunicamycin, 100 nM staurosporine, or 10−6 M dexamethasone. 
The percentages of viable cells in culture were determined by annexin V/PI 
staining and fl  ow cytometric analysis. The extent of apoptosis induced 
specifi  cally by different stimuli was calculated by the following equation: 
(induced apoptosis − spontaneous cell death)/(100 − spontaneous cell 
death). Means ± SEM (error bars) from four independent experiments 
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loss of Bim caused an increase in the levels of all Ig isotypes 
tested (IgM, IgG1, IgG2a, IgG2b, IgG3, and IgA), and this 
increase was similar in the extent seen in vav-bcl-2 tg mice 
(Fig. 6 a). The loss of Puma on its own did not cause any 
abnormality in serum Ig levels, with one notable  exception—
that of the increased levels of IgA (P = 0.05). The com-
bined loss of both Bim and Puma did not lead to a further 
increase in serum IgM and IgG levels compared with that 
seen in bim−/− mice. Consistent with the observation in 
puma−/− mice, IgA levels were clearly higher in bim−/−/
puma−/− animals than in bim−/− mice (P = 0.0005; Fig. 
6 a), indicating that Bim and Puma coregulate the lifespan 
of IgA-secreting plasma cells.
Consistent with the notion that Bim-defi  cient B cells es-
cape negative selection and have an abnormal tendency to 
escape anergy in response to challenge with autoantigens, we 
observed signifi  cantly increased titers of anti–double-stranded 
DNA (dsDNA) antibodies in serum samples of 12-mo-old 
bim−/− and bim−/−/puma−/− mice compared with sera from 
WT or puma−/− mice (P ≤ 0.05; Fig. 6 b). Sera of aged mice 
lacking Bim or Bim plus Puma also showed  immunoreactivity 
with the nuclei in rat liver sections (Fig. 6 c), confi  rming 
the presence of antinuclear antibodies (ANAs). However, 
  fatal autoimmune glomerulonephritis as observed in bim−/− 
mice on the mixed genetic background was not observed in 
any of the bim−/− (n = 15), bim−/−/puma+/− (n = 10), or 
bim−/−/puma−/− (n = 7) animals analyzed at 12 mo of age 
(Fig. 6 c and not depicted). These results indicate that Bim 
may be the dominant inducer of the programmed death of 
activated B cells, but Puma may play a minor contributory 
role, particularly in IgA-secreting plasma cells.
Mice lacking Bim and Puma are prone 
to lymphoma development
When combined with aberrant c-myc oncogene activation, 
the loss of Bim or the knockdown of Puma was shown to 
  accelerate lymphomagenesis in mice (22, 23), but spontane-
ous tumor development has not been assessed in mice lacking 
Bim, Puma, or both. To investigate whether the combined 
loss of Bim and Puma can cause spontaneous tumor forma-
tion, we followed a cohort of bim−/−/puma−/−,  bim−/−/
puma+/−, bim+/−/puma−/−, bim−/−, puma−/−, and WT mice 
for 12 mo and performed detailed necropsy. No signs of 
  malignancy were observed in 1-yr-old WT (0/12) or puma−/− 
animals (0/14), but neoplastic disease of the hemopoietic sys-
tem was observed in 20% of animals lacking Bim (3/15). 
Consistent with an overlapping role for Bim and Puma in 
  tumor suppression, we observed signs of malignancies in 50% 
(5/10) of bim−/−/puma+/− mice (but 0% of the bim+/−puma−/− 
mice; 0/13) and in  60% of bim−/−/puma−/− mice (4/7) that 
were still available for analysis.
Flow cytometric and histopathological assessment re-
vealed a tumor pattern similar to the one described in aged 
vav-bcl-2 tg mice (24), including B220+ follicular and diff  use 
large B cell lymphomas (Fig. 7, a and b; and Fig. S5, available 
at http://www.jem.org/cgi/content/full/jem.20061552/DC1), 
but histiocytic sarcomas were also observed in bim−/− mice 
lacking one or both alleles of puma (one per genotype; Fig. 7 c). 
In lymphoma cases, lymph node architecture was completely 
eff   aced by either nodular/follicular or diff  usely  spreading 
neoplastic blasts, invading the lymph node capsule and, in 
cases of extranodal involvement, expanding onto the organ 
submucosae and laminae propriae with focal hypoepithelial 
lesions. In addition, immunohistochemical analysis of expres-
sion levels of the B cell marker B220 and the proliferating cell 
nuclear antigen (PCNA) revealed high levels of both pro-
teins and high mitotic indices in all lymphoma cases tested 
(Figs. S5 and S6; and not depicted). Histiocytic   sarcoma infi  l-
trated spleen and lymph nodes and consisted of undiff  erenti-
ated epithelioid and spindle cells with abundant mitoses and 
scattered tumor giant cells (Fig. 7 c). Transplantation of bone 
marrow from 12-mo-old bim−/−puma−/− mice with B cell 
lymphomas into irradiated recipients caused rapid overt 
  disease 10 wk after reconstitution (Fig. S7). This phenome-
non was never observed when bone marrow from young 
8–12-wk-old double-defi  cient donors was used; these cells 
effi     ciently reconstituted normal hemopoiesis, but without 
signs of malignancy over an observation period of >20 wk 
(unpublished data). In addition to the malignant changes, 
hyperplastic infi   ltrations were frequently observed in the 
  kidney, liver, and lung of aged bim−/−,  bim−/−/puma+/−, 
and bim−/−/puma−/− mice (Fig. 7, d–f; and not depicted). 
Although preliminary, these observations confi  rm that BH3-
only proteins can function as tumor suppressors and provide 
Figure 5.  Bim and Puma cooperate in dexamethasone-induced 
T cell apoptosis in vivo. Mice of the indicated genotypes were injected 
i.p. with 500 μg saline or dexamethasone and killed 20 h later. Thymic 
cellularity was assessed using a hemocytometer and trypan blue exclusion. 
(a) The percentages of the CD4+8+ thymocytes and total thymic cellularity 
were used to calculate the absolute number of CD4+8+ thymocytes. 
(b) Absolute numbers of CD4+ and CD8+ splenic T cells were determined 
by staining single-cell suspensions with antibodies specifi  c for CD4 and 
CD8 followed by fl  ow cytometric analysis. Combined results ± SD (error 
bars) from two independent experiments and n ≥ 2 animals per genotype 
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evidence that Bim and Puma may have overlapping roles in 
this process.
D  I  S  C  U  S  S  I  O  N 
Previous analysis of animals lacking either Bim or Puma sug-
gested very distinct physiological roles for the individual 
BH3-only proteins. Puma is considered to be the prime ef-
fector of p53 in DNA damage–induced apoptosis in cell types 
as diverse as lymphocytes, fi  broblasts, and the central nervous 
system (13, 14, 25). Bim, on the other hand, seems to be 
most critical in the hemopoietic compartment, where it plays 
crucial roles in the deletion of autoreactive T and B cells, the 
termination of humoral immune responses, and leukocyte 
homeostasis in general (1). Experiments investigating cell 
death induction in cultured cells exposed to a wide range of 
apoptotic stimuli suggested functional redundancy between 
Bim and Puma. For example, the absence of either of these 
BH3-only proteins delayed apoptosis induced by cytokine 
withdrawal or treatment with GCs both in vitro and in vivo 
(6, 14, 15). Therefore, we investigated the possible functional 
overlap between these BH3-only proteins by generating 
double-defi  cient mice.
Bim defi  ciency was previously reported to cause the loss 
of a certain number of embryos on the mixed 129SV×C57BL/6 
genetic background before embryonic day (E) 9.5 (6). This 
phenotype is maintained after backcrossing to C57BL/6, but 
the reason remains unknown (this study and unpublished 
data). Double-defi  cient animals and Bim-defi  cient animals 
were both born with a frequency between 40 and 44%, re-
spectively, indicating that the additional loss of puma does not 
enhance the embryonic lethality caused by the loss of Bim. 
Given the low numbers of animals derived from these initial 
intercrosses (n = 183), more animals may be needed to allow 
stringent statistical analysis.
The combined loss of Bim and Puma did not markedly 
impair tissue homeostasis in nonhemopoietic organs such as 
the heart, lung, kidney, or liver, but minor abnormalities or 
defects in numerically small cell subsets may have escaped 
our attention. This may indicate that in bim−/−/puma−/− 
mice that successfully complete embryonic development, ad-
ditional proapoptotic factors can maintain normal levels of 
programmed cell death. However, the combined loss of Bim 
and Puma did signifi  cantly enhance lymphadenopathy and 
splenomegaly, which are also observed in bim−/− mice (P = 
0.007), and, interestingly, also created novel defects such as 
thymic hyperplasia (Figs. 1 and 2). The thymic hyperplasia 
seen in bim−/−/puma−/− mice appears to depend on a thymo-
cyte-independent contribution, possibly increased thymic 
epithelial cell survival, in combination with strongly de-
creased thymocyte apoptosis (see bone marrow   reconstitution 
Figure 6.  Enhanced Ig and autoantibody production in bim−/−, 
bim−/−/puma−/−, and vav-bcl-2 tg mice. (a) Ig titers in sera from 
8–12-wk-old mice of the indicated genotypes were quantifi  ed by ELISA. 
(b) Autoantibodies to dsDNA were quantifi  ed in sera from 12-mo-old mice 
of the indicated genotypes by ELISA using calf thymus dsDNA for coating. 
(c) Representative ANA staining on rat liver sections using serum from a 
bim−/−/puma−/− animal. (d) Representative hematoxylin and eosin stain 
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experiments in Fig. S3). Interestingly, thymic hyperplasia was 
not observed in animals reconstituted with bax−/−/bak−/−-
defi  cient bone marrow (26), and it would be interesting 
to know whether hyperplasia can develop in mice lacking 
Bax/Bak both in hemopoietic cells and the thymic stroma. 
Therefore, this phenotype is unique to animals lacking Bim 
and Puma. The combined loss of Bim and Blk (27), Bim and 
Bad (unpublished data), or Bim and Bmf (unpublished data) 
does not cause thymic hyperplasia, demonstrating that this 
defect is caused specifi  cally by the combined absence of Bim 
and Puma and not by the combined loss of Bim and just any 
BH3-only protein.
All developmental defects found in bim−/−/puma−/− thy-
mocytes were highly similar, albeit more pronounced than 
the ones observed in bim−/−mice (7). The percentages of 
CD4+8+ DP cells were further reduced in the absence of 
Bim and Puma than in the absence of Bim alone (Fig. 1), in-
dicating that the enhanced accumulation of mature T cells 
through a presently unknown negative feedback may further 
impede the proliferation of immature pro–T cells. A similar 
reduction in CD4+8+ DP thymocytes was also seen in  lethally 
irradiated mice reconstituted with a Bax/Bak double-defi  cient 
hemopoietic system (26).
It has previously been reported that the activation of p53 
restricts the survival of DN thymocytes that fail to rearrange 
their TCR-β chain, which is required to secure the transi-
tion of developing thymocytes from the CD4−8− DN to the 
CD4+8+ DP stage (28). However, the percentage and num-
bers of TCR-β+ DN thymocytes did not diff  er between 
WT and puma−/− mice (Fig. 1), confi  rming the notion that 
the loss of p53 but not simply the inhibition of apoptosis 
downstream of p53 is required to rescue pre–T cells from 
the detrimental consequences of impaired or lacking pre-
TCR signaling (28). Accordingly, the accumulation of DN 
thymocytes observed in bim−/−, bim−/−/puma−/−, or vav-bcl-2 
tg mice is not caused by the survival of cells that failed β 
  selection because most of these cells do express a TCR-β 
chain (Fig. 1).
In contrast to early thymocyte development, apoptosis 
during early B cell development appears to be regulated 
mainly, albeit not exclusively, by Bim. Bone marrow cellular-
ity was found to be signifi  cantly increased only in vav-bcl-2 tg 
mice (P = 0.048), but the percentage and number of 
B220+CD43+sIgM− pro–B cells was also elevated in bim−/− 
mice (Table S1). This increase was not enhanced by the addi-
tional loss of Puma. Consistent with previously published data 
(29), pre–B cell numbers were not abnormally increased in 
bim−/− mice (Table S1), and the additional loss of Puma had 
no eff  ect. Collectively, our fi  ndings confi  rm that Bcl-2 and 
Bim do play a crucial role in early pro–B cell survival but 
not in maturation downstream of the IL-7/IL-7R signaling 
  pathway. The role of Bim in early B cell development appears 
to overlap with other proapoptotic factors because vav-bcl-2 tg 
mice show about a twofold excess of B220+CD43+sIgM− 
pro–B cells compared with bim−/− mice (Table S1).
The splenomegaly that is caused by the combined defi  -
ciency of Bim and Puma exceeds the one found in bim−/− 
mice (6) and matches the one observed in vav-bcl-2 tg mice 
(16). All T and B lymphocyte subsets in bim−/−/puma−/− 
were signifi  cantly elevated in cellularity when compared with 
bim−/− mice (P ≤ 0.015) but were no longer statistically dif-
ferent from age-matched vav-bcl-2 tg mice (Fig. 2).   Therefore, 
the overexpression of Bcl-2 under control of the vav-gene 
promoter is suffi   cient to antagonize Bim and Puma function 
during lymphocyte homeostasis. In line with this hypothesis, 
we observed that the combined overexpression of Bcl-xL and 
Bcl-2 did not cause a further increase in the numbers of 
  mature T cells (unpublished data), suggesting functional re-
dundancy between Bcl-2 and Bcl-xL in the control of mature 
T cell survival.
The increase of CD44highCD62Llow T cells in bim−/−/
puma−/− mice strongly suggested a nonredundant role for 
these BH3-only proteins in the deletion of activated T cells. 
Consistently, T cell blasts derived from bim−/−/puma−/− ani-
mals survived IL-2 deprivation–induced death better than 
bim−/− T cell blasts and, indeed, almost as strongly as those 
overexpressing Bcl-2 (Fig. 3 a). Although the loss of Puma on 
Figure 7.  Combined loss of Puma and Bim promotes spontaneous 
tumor formation. (a and b) Follicular B cell lymphoma found in the 
  mesenteric lymph nodes of a 12-mo-old bim−/−puma−/− mouse (a) 
  expanding into the submucosae and lamina propriae of the small gut (b). 
(c) One 12-mo-old bim−/−/puma−/− mouse developed a histiocytic sar-
coma of the spleen. (d–f) Hyperplastic lymphocyte infi  ltrations were ob-
served in the kidneys (d), liver (e), and lung (f), in part showing signs 
of malignancy (see lymphoepithelial lesions of the bronchus in f). 
Bars (a), 300 μm; (b–d), 200 μm; (e and f), 150 μm.JEM VOL. 203, December 25, 2006  2949
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its own provided only transient protection from IL-2 depri-
vation, our data show that Puma can contribute to the shut-
down of an immune response, particularly when Bim function 
is impaired. Transcriptional activation of puma in IL-2–
  deprived T cell blasts may be achieved independently of p53 
by the forkhead transcription factor family member FOXO3a 
(30), which is also known to regulate the expression of Bim 
under these conditions (31).
However, our experiments using the injection of SEB did 
fail to establish clear synergy between the loss of Bim and the 
loss of Puma in the survival of activated Vβ8+ T cell clones 
(Fig. 3, b and c). Unfortunately, we were unable to follow 
the fate of SEB-activated T cells for >6 wk because of the 
limited number of animals available and, therefore, can only 
speculate that Bim/Puma double-defi  cient T cells may persist 
longer in vivo. Nevertheless, our fi  ndings are in line with a 
previous study demonstrating that the absence of Bim strongly 
delays but does not completely prevent the deletion of SEB-
activated T cells (10).
The prolonged persistence of activated T cells lacking 
Bim may contribute to autoimmunity, and, on the mixed 
genetic background, the loss of Bim causes the production 
and accumulation of antibodies leading to autoimmune 
glomerulonephritis (6). Although bim−/− mice on an inbred 
C57BL/6 background do produce autoantibodies and have 
increased Ig titers, they no longer succumb to immune com-
plex glomerulonephritis (reference 20; and this study). The 
additional loss of Puma did not restore autoimmune glomer-
ulonephritis in bim−/−/puma−/− mice. Moreover, the levels 
of total IgM or IgG and anti-dsDNA autoantibodies detected 
in bim−/− mice were not further increased in bim−/−/puma−/− 
mice and were comparable with those observed in vav-bcl-2 
tg mice (Fig. 6). Interestingly, however, there was a signifi  -
cant increase in IgA found in puma−/− mice compared with 
WT mice (P = 0.05) and more IgA in bim−/−/puma−/− mice 
compared with bim−/− mice. This may indicate that Puma, 
not only Bim, protects against IgA nephropathy (32).
Cell death analysis performed on isolated lymphocytes 
confi  rmed the redundant function of Bim and Puma most 
prominently in spontaneous but also stress-induced apoptosis. 
Apoptosis induced by GCs, γ irradiation, or treatment with 
DNA-damaging drugs, pankinase inhibitors, or ER stressors 
was more effi   ciently blocked in Bim/Puma double-defi  cient 
cells when compared with cells lacking the individual genes 
(Figs. 4 and 5). Studies performed on lymphoid cells from 
bim−/−/blk−/− (27) or bim−/−/bad−/− double-defi  cient mice 
(unpublished data) failed to demonstrate redundancy in cell 
death initiation between Bim and these two BH3-only pro-
teins and, therefore, argues against the possibility that the 
  observed eff  ects are simply caused by increases in the pool of 
Bcl-2 prosurvival family members that are not bound to 
BH3-only proteins. Finally, the combined loss of Puma and 
Bim did not lead to the increased resistance of thymocytes to 
phorbol ester or ionomycin, indicating that the observed syn-
ergy is not a general one but is stimulus dependent (Fig. S4 a). 
Because the overexpression of Bcl-2 proved to be more 
  potent in protecting lymphocytes from stress-induced cell 
death than the combined loss of Bim and Puma (Fig. 4), the 
activation of other BH3-only proteins must be assumed. 
However, neither Bid, Bad, Bmf, Bax, nor Bak  compensatory 
up-regulation was observed in thymocytes lacking Bim and 
Puma (unpublished data). Using fl  ow cytometric (Fig. S4, b 
and c) and Western blotting analysis (not depicted), we also 
observed that thymocytes lacking Bim and Puma effi   ciently 
activated caspase-3 and cleaved poly-ADP ribose polymerase 
in response to various inducers of cell death (cytokine depri-
vation, GC, or etoposide treatment), albeit with delayed  kinetics, 
indicating that Bax and/or Bak can be activated eff  ectively in 
the absence of Bim and Puma.
Previously published data proposed that the loss of Bim 
is only poorly tumorigenic on its own but does accelerate 
c-myc oncogene-driven lymphomagenesis in mice (23). 
  Interestingly, the loss of Bim has been found in patients with 
mantle cell lymphoma and renal cell carcinoma. In contrast, 
although intensely investigated in carcinomas of the lung, 
colon, or head and neck in humans, no mutations aff  ecting 
the puma locus have been detected (33). Puma must have 
tumor suppressor potential based on the observation that 
its loss or reduced expression also promotes c-myc–induced 
lymphomagenesis (22). Consistently, we observed spontane-
ously occurring malignancies in 20% of bim−/− mice within 
12 mo of age. Interestingly, half of the bim−/−/puma+/− mice 
and  60% of the double-defi  cient animals showed signs of 
neoplastic growth (Fig. 7 and Figs. S5 and S6). Our observa-
tions are in line with data demonstrating that a reduction of 
Puma expression levels by RNA interference is able to accel-
erate c-myc–induced lymphomagenesis (22), as does the hap-
loinsuffi   ciency of Bim (23). Whether the additional loss of 
one allele of puma signifi  cantly increases the observed tumor 
incidence further will require the analysis of lager cohorts 
of animals. Our data indicate that the loss of Bim is more 
important for the development of lymphoid malignancy 
than the loss of Puma because bim+/−/puma−/− animals did 
not develop any tumors over the same observation period. 
Further genetic studies will be required to assess the full tu-
mor spectrum suppressed by Bim and Puma. Disease models 
derived from these studies will be useful tools to assess the 
therapeutic potential of small molecule drugs such as BH3 
mimetics that hold much promise for the treatment of cancer 
in the near future.
MATERIALS AND METHODS
Mice. All animal experiments were performed in accordance with the 
  Austrian Tierversuchsgesetz (BGBl. Nr. 501/1988 i.d.g.F) and have been 
granted by the Bundesministerium für Bildung, Wissenschaft, und Kultur. 
The generation and genotyping of the puma−/−, bim−/−, lck-bcl-xL, and 
vav-bcl-2 tg mice have been described previously (6, 14, 16). C57BL/6-Ly5.1 
mice were purchased from Charles River Laboratories.
Cell culture and reagents. Primary hemopoietic cells were cultured in 
RPMI 1640 medium (PAA Laboratories) supplemented with 13 μM folic 
acid, 250 μM l-glutamine (Invitrogen), 50 μM 2-mercaptoethanol, nones-
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and 10% FCS (Invitrogen). For the induction of cell death, FLAG epitope-
tagged FasL (Qbiogene) was used at 100 ng/ml together with cross-linking 
M2 anti-FLAG antibody (Sigma-Aldrich) at 1 μg/ml. Ionomycin (Sigma-
Aldrich) was used at 1 μg/ml, PMA was used at 10 ng/ml (Sigma-Aldrich), 
etoposide (Sigma-Aldrich) was used at 1 or 10 μg/ml, the ER stressor tunic-
amycin (Sigma-Aldrich) was used at 10 μg/ml, and the GC dexamethasone 
was used at 10−6 or 10−7 M. Injections of saline, dexamethasone (Dexabene; 
Merckle Recordati), or SEB (Sigma-Aldrich) were performed i.v. in a fi  nal 
volume of 200 μl.
Immunofl   uorescence staining, fl   ow cytometric analysis, and cell 
sorting. Single-cell suspensions from the bone marrow, lymph nodes, 
spleen, and thymus were surface stained with monoclonal antibodies 
  conjugated with FITC, R-PE, allophycocyanin, or biotin (Invitrogen). The 
monoclonal antibodies used and their specifi  cities are as follows: RA3-6B2, 
anti-B220; GK1.5, anti-CD4; H129.19.6.8, anti-CD4; 53.6.72, anti-CD8; 
YTS 169, anti-CD8; RB6-8C5, anti–Gr-1; S7, anti-CD43; 5.1, anti-IgM; 
11/26C, anti-IgD; MI/70, anti–Mac-1; Ter119, antierythroid cell surface 
marker; T24.31.2, anti–Thy-1; IM7, anti-CD44; PC61, anti-CD25; MEL-14, 
anti-CD62L; H57-59, anti–TCR-β; F23.1, anti-Vβ8; RR4-7, anti-Vβ6; 
A20, anti-Ly5.1; 1D4, anti-Ly5.2; and anti-CD3, 2C11. Flow cytomet-
ric  analysis was performed using a FACSCalibur cell analyzer (Beckton 
Dickinson). Isolation of cells was performed using a FACSVantage cell sorter 
(Beckton Dickinson).
Immunohistochemistry. Formalin-fi  xed  paraffi   n-embedded  sections  of 
lymphomas were stained for the presence of the B cell marker B220 (RA3-
6B2) or the proliferation marker PCNA (PC10) according to protocols 
  accessible online under www.ihcworld.com.
Cell death assays. The percentages of viable cells in culture were deter-
mined by staining cell suspensions with 2 μg/ml PI plus FITC-coupled 
  annexin V followed by analysis in a FACScan (Becton Dickinson). Alternatively, 
cells were stained with trypan blue (0.1% in PBS) and analyzed in a 
  hemocytometer (Neubauer chamber; Sigma-Aldrich). For the detection of 
active caspase-3, cells were fi  xed in 4% paraformaldehyde for 10 min, washed 
in PBS, and permeabilized in methanol for 1 h at −20°C. AlexaFluor488-
conjugated antiactive caspase-3 antibody (Cell Signaling) was used in at a 
1:100 dilution for intracellular staining in PBS/BSA.
Generation of T cell blasts. Spleens were pushed through a steel sieve, 
and single-cell suspensions were subjected to RBC lysis. Cells were spun 
over a cushion of FCS and washed twice in medium. 107 spleen cells were 
incubated for 20 min on ice with a cocktail of antibodies recognizing the 
B cell marker B220 (RA3-6B2), the myeloid cell marker Mac-1 (MI/70), 
the granulocyte marker Gr-1 (S7), and the erythroid cell marker Ter119. 
After incubation, cells were washed in 10 ml PBS and spun over a cushion 
of FCS. The pellet was resuspended in 500 μl PBS/FCS solution, and cells 
were incubated on ice with anti–rat IgG–specifi  c Dynabeads for 20–30 min 
under gentle agitation (Dynal). Negatively sorted T cells (purity of >90%) 
were stimulated with 2 μg/ml ConA (Sigma-Aldrich) and 100 U/ml IL-2 
(PeproTech) for 3 d to generate activated T cell blasts. These cells were 
washed twice in PBS and subjected to cytokine withdrawal. Viability was 
assessed by PI exclusion and fl  ow cytometric analysis.
Quantifi  cation of Ig titers and autoantibody production. Ig titers in 
the serum from 8–12-wk-old mice were quantifi  ed using an Ig clonotyping 
system (Southern Biotechnology Associates, Inc.) according to the manufac-
turer’s instructions. Serum samples were used in a dilution range from 
1:1,000 to 1:160,000 depending on the isotype to secure absorbance read-
ings in a linear range. Calf thymus DNA (Sigma-Aldrich) in 12.5 μg/ml 
of distilled water was allowed to bind overnight to 96-well ELISA plates 
(Costar) precoated for 1 h at 37°C with poly-l-lysine (0.1% in distilled 
  water). For anti-dsDNA autoantibody detection, a horseradish peroxidase–
labeled goat anti–mouse Ig(H+L)–specifi  c antibody and ABTS as a substrate 
were used (Southern Biotechnology Associates, Inc.). Mouse sera were di-
luted 1:100 in 1% PBS/BSA. Serum derived from autoimmune-prone New 
  Zealand white/New Zealand black F1 mice was used as a positive control.
ANA stainings were performed on 5-μm cryosections from rat liver. 
Serum samples were diluted 1:30 in PBS. Cryosections were fi  xed in ace-
tone for 10 min and subsequently incubated with the diluted serum sample 
for 30 min. After washing in PBS for 30 min, sections were incubated with 
AlexaFluor488-conjugated goat anti–mouse IgG (Invitrogen) for an addi-
tional 30 min (1:600 in PBS). Finally, slides were washed twice in PBS for 
45 min, and the sections were covered with MOWIOL mounting media 
and a glass coverslip. Images were acquired using a laser-scanning micro-
scope (Axiovert; Carl Zeiss MicroImaging, Inc.).
Preparation of histological sections. Organs were fi  xed in 4% paraformal-
dehyde in PBS, processed according to standard procedures, and stained in 
hematoxylin and eosin.
Statistical analysis. Statistical analysis was performed using the unpaired 
Student’s t test or analysis of variance where indicated and applying the Stat-
View 4.1 software program (Abacus Concepts). P-values of <0.05 were 
considered to be statistically signifi  cant.
Online supplemental material. Fig. S1 shows normal organ development 
in live-born Bim and Bim/Puma double knockout mice. Fig. S2 shows that 
bim−/−/puma−/− mice develop multiple defects postnatally. Fig. S3 shows 
that lymphadenopathy in bim−/−/puma−/− mice involves eff  ects originating 
outside the bone marrow. Fig. S4 shows that the synergy between Bim and 
Puma in cell death initiation is stimulus dependent. Fig. S5 shows spontane-
ous tumorigenesis in mice lacking Bim and Puma, and Fig. S6 shows PCNA 
expression analysis in tumor samples. Fig. S7 shows the histopathological 
assessment of transplanted tumor material. Table S1 provides data about ab-
normal bone marrow composition in Bim/Puma double knockout mice. 
Table S2 shows that bim−/−/puma−/− mice display enlarged lymph nodes, 
and Table S3 provides an analysis of leukocyte composition in the peri-
pheral blood. Online supplemental material is available at http://www.jem.
org/cgi/content/full/jem.20061552/DC1.
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